Effect of Rasnadi Guggulu , Rasnadashamooladi Kwatha and Griva Vasti in Cervical Spondylosis

Phase 2

Completed

• Conditions: Health Condition 1: null- Cervical Spondylosis

• Registration Number: CTRI/2018/05/014141
• Lead Sponsor: ational Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients willing to signature the consent form for the clinical trial.

2.Patients of either sex.

3. Patients above 20 years and less than 70 years.

4. Clinical symptoms of ââ?¬Ë?Griva-Sandhigata Vataââ?¬• (Cervical Spondylosis) with or without radiological changes.

Exclusion Criteria

1.Stenosis of spinal cord

2.Contraindication and allergy to any drug in Rasnadi Guggulu, Rasnadashamooladi Kwatha or Dashamooladi Taila used for Griva Vasti.

3.Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy.

4.Myofacial pain

5.Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), chronicdisease (like rheumatoid arthritis, SLE, ankylosing spondylitis).

6.Pregnant and lactating mothers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reduction of cervical painTimepoint: 1 month

Secondary Outcome Measures

Name	Time	Method
improvement of quality of lifeTimepoint: 1 month